Investors

Monte de Piedad y Caja de Ahorros de Huelva y Sevilla is a Federal Savings Institution.

Metris NV provides metrology solutions for dimensional quality control to the engineering and manufacturing departments of automotive and aerospace companies, and their suppliers worldwide. Its solutions include measuring hardware, application software, and customer services. The company’s products consist of coordinate measuring machine (CMM), a mechanical motorized system designed to move a measuring probe (or sensor) to determine the coordinates of points on the surface of an object. It offers three types of fixed CMMs, including bridge, horizontal arm, and gantry CMMs.

Industrial Growth Partners is a private equity firm specializing in privately held lower middle market companies. The firm typically invests in change in ownership transactions such as management buyouts, private companies and family-owned companies, leveraged buyouts, corporate divestitures, co-operative divestitures, recapitalizations, and management buy-ins and also provides growth capital.

Florida Capital Partners, Inc. (FCP) is a private investment firm specializing in recapitalization, management buyout and buy-in, corporate divestiture, family succession, and industry consolidation transactions. The firm seeks to invest in small and medium sized companies. It prefers to invest in companies engaged in the niche manufacturing, specialty services, and value added distribution sectors. The firm typically invests in companies based within the continental United States.

CEI Ventures, Inc. is the venture capital investment arm of Coastal Enterprises, Inc. specializing in early stage investments. It seeks to invest in companies that are emerging, growing, or undergoing transformation. The firm primarily invests in companies in the underserved markets through out the Northeastern United States. It typically invests between $500,000 and $2 million with an average of $750,000, often through multiple financings. The firm prefers to exit its investment between five years and seven years. It seeks to take a board seat in its portfolio companies.

Asys Hitech GmbH designs, develops, and manufactures microplate instrumentation and software for life science and healthcare companies. The company’s products include microplate readers, microplate washers, six plate microplate dispensers, two plate microplate dispensers, shakers and incubators, and manual wash systems. It also offers software for microplate data reduction application. The company was founded in 1992 and is based in Eugendorf, Austria. As of December 6, 2001, Asys Hitech GmbH is a subsidiary of Biochrom Ltd.

Aberdeen Asset Managers Private Equity Ltd. is a private equity firm specializing in management buyouts, buy-ins, turnarounds, acquisition finance, replacement capital, and developmental capital investments. The firm also invests growth capital in new and secondary AIM issues. It prefers to invest in support services, specialist manufacturing, consumer and leisure, and financial services sectors. The firm typically invests in companies based in the United Kingdom. It seeks to invest between £1 million ($1.86 million) and £20 million ($37.3 million).

Venture Investors, LLC is a venture capital firm specializing in investments in seed, early stage, and emerging markets. It primarily invests in healthcare and information technology sectors. Within healthcare, the firm invests in biotechnology, diagnostics and therapeutics, human health, drug discovery, new drug delivery technologies, new enabling technologies, and medical devices.

Temasek Holdings (Pte), Ltd. is a private equity firm specializing in growth capital, restructuring, and divestiture transactions. The firm also invests in private equity and debt funds, such as buyout and growth capital funds, mezzanine funds, debt funds, technology venture capital funds, and life sciences venture capital funds.

Queensland BioCapital Funds Pty Ltd. is an investment arm of Queensland Investment Corporation specializing in investments in seed or start up, early venture, emerging growth, growth capital, mid venture, late venture, buyouts, recapitalizations, industry consolidations, middle market, mature, and mezzanine financing of biotechnology companies in Australia. It invests in companies that provide exploitable technology capable of development into several different drug, disease treatment or lifestyle products.